QA: Cue Biopharma Inc. in us_pharma/2021

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001645460_2022_Cue_Biopharma_Inc.pdf

Logs

Graph

Absolute values for 0001645460, Cue Biopharma Inc.

  xvar xval
0 AssetsCurrent 68,468,119
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 2,111,949
3 remainder_Assets 12,820,867
4 LiabilitiesCurrent 12,787,684
5 LiabilitiesNoncurrent 5,121,179
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 17,306,678
9 ResearchAndDevelopmentExpense 41,346,765
10 remainder_Expenses 495,000
11 remainder_Revenues 14,941,370
12 remainder_NetIncome 45,898
13 remainder_ComprehensiveNetIncome -7,131
  yvar yval
0 Assets 83,400,935
1 Liabilities 17,908,863
2 Expenses 59,148,443
3 Revenues 14,941,370
4 StockholdersEquity 65,492,072
5 NetIncome -44,161,175
6 ComprehensiveNetIncome -44,164,740
7 BaseVar 87,726,320
8 EconomicCapitalRatio 1.35

Edgar->Model Mapping

Feature Distribution

Change over Time